KROPSEN
Live / Registered — Registered (as of 28 Jun 2022)
What this means for you
Registered since 28 Jun 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90738037
- Registration number
- 6771682
- Mark type
- Stylized text
- Filed
- 27 May 2021
- Published for opposition
- 12 Apr 2022
- Registered
- 28 Jun 2022
- Attorney of record
- Bharati Bakshani
Goods and services
- Class 005 — Pharmaceuticals: Chemical preparations for pharmaceutical or medical purposes, namely, for prevention and treatment of cancer; Tumor suppressing agents; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations for the prevention, diagnosis, treatment and adjunctive therapy of coronaviruses, Covid-19, influenza viruses, influenza A, influenza B, SARS-CoV-1, SARSCoV-2, MERS-CoV, and rhinoviruses; Mixed biological preparations for the prevention and treatment of infectious diseases; Biological preparations for the treatment of cancer; Anti-cancer preparations; Medicinal preparations for stimulating hair growth; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Pharmaceutical products for the prevention and treatment of cancer; Medicinal hair growth preparations; Acne treatment preparations; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Nutraceuticals for the treatment of infectious diseases, inflammation, alopecia,and cancer
Owner
- Suzhou Kintor Pharmaceuticals, Inc., Suzhou City, CN
- Suzhou Kintor Pharmaceuticals, Inc., Suzhou City, CN
- Suzhou Kintor Pharmaceuticals, Inc., Suzhou City, CN
Prosecution history
- 28 Jun 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Jun 2022 — REGISTERED-PRINCIPAL REGISTER
- 12 Apr 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Apr 2022 — PUBLISHED FOR OPPOSITION
- 23 Mar 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Mar 2022 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 04 Mar 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Feb 2022 — EXAMINER'S AMENDMENT ENTERED
- 24 Feb 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 24 Feb 2022 — EXAMINERS AMENDMENT E-MAILED
- 24 Feb 2022 — EXAMINERS AMENDMENT -WRITTEN
- 16 Feb 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Feb 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Feb 2022 — ASSIGNED TO LIE
- 14 Feb 2022 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED